Recombinant Vibrio vulnificus 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mtnN; VV0635; 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase; MTA/SAH nucleosidase; MTAN; EC 3.2.2.9; 5'-methylthioadenosine nucleosidase; MTA nucleosidase; S-adenosylhomocysteine nucleosidase; AdoHcy nucleosidase; SAH nucleosidase; SRH nucleosidase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-231
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
mtnN
Target Protein Sequence
MKVGIIGAMQ QEVAILKEAM TNAQTVNKAG CTFYSGQING VEVVLLQSGI GKVAAAIGTT ILLDEYQPDM VLNTGSAGGF DSSLNLGDVV ISTEVRHHDA DVTAFGYEMG QMAGQPAAFL ADEKLMNLAE KALEQMDGQH AVRGLICTGD AFVCTAERQA FIRQHFPSVI AVEMEASAIA QTCHQFKVPF VVVRAISDVA DKESPMSFEE FLPLAAKSSS EMVFKMLELL K
Uniprot No.

Target Background

Function

This enzyme catalyzes the irreversible cleavage of the glycosidic bond in both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH/AdoHcy), yielding adenine and the corresponding thioribose derivatives (5'-methylthioribose and S-ribosylhomocysteine, respectively). It also cleaves 5'-deoxyadenosine, a toxic byproduct of radical S-adenosylmethionine (SAM) enzymes, into 5-deoxyribose and adenine.

Database Links

KEGG: vvy:VV0635

Protein Families
PNP/UDP phosphorylase family, MtnN subfamily

Q&A

What is the function of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) in Vibrio vulnificus?

5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN, also known as MTAN) in Vibrio vulnificus is a bacterial enzyme involved in S-adenosylmethionine-related quorum sensing pathways that induce bacterial pathogenesis factors . The enzyme catalyzes the hydrolysis of the glycosidic bond in 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH), releasing adenine and the corresponding thioribose derivatives.

This enzymatic activity is crucial for:

  • Methionine recycling through the methylthioadenosine (MTA) cycle

  • Regulation of quorum sensing pathways that control virulence gene expression

  • Production of autoinducer-2 (AI-2), a key quorum sensing signal molecule

  • Maintenance of bacterial growth in various environmental conditions

The disruption of mtnN activity can significantly impair quorum sensing, which is directly linked to the expression of virulence factors such as the multifunctional-autoprocessing RTX (MARTX) toxins that contribute to V. vulnificus pathogenicity .

How does mtnN contribute to Vibrio vulnificus pathogenicity?

The mtnN enzyme significantly contributes to V. vulnificus pathogenicity through several interconnected mechanisms:

  • Quorum Sensing Regulation: mtnN is essential for the production of autoinducer-2 (AI-2) signaling molecules that enable bacteria to coordinate gene expression in a population density-dependent manner .

  • Virulence Factor Expression: Through its role in quorum sensing, mtnN indirectly regulates the expression of various virulence factors, including:

    • RTX toxins, particularly the MARTX(Vv) toxin that is an important virulence factor demonstrated in the intragastric route of infection in mice

    • Proteases and hemolysins that contribute to tissue damage

    • Siderophores for iron acquisition during infection

  • Genetic Variation Impact: Research has shown that the rtxA1 gene in V. vulnificus, which encodes the MARTX toxin, has four distinct variants with different arrangements of effector domains . The metabolic pathways involving mtnN may influence the expression and function of these toxin variants.

  • Biofilm Formation: mtnN activity promotes biofilm development, enhancing bacterial survival in hostile environments and contributing to colonization during infection.

Interestingly, studies have found that the most common rtxA1 gene variant in clinical-type V. vulnificus encodes a toxin with reduced potency compared to those isolated from market oysters , suggesting potential selection for altered virulence in different environments.

What are the optimal methods for determining kinetic parameters of recombinant Vibrio vulnificus mtnN?

Determining accurate kinetic parameters for recombinant V. vulnificus mtnN requires robust methodological approaches. The following techniques offer complementary advantages:

Isothermal Titration Calorimetry (ITC) with Multiple Injection Method (MIM):
This technique directly measures heat released during enzyme catalysis, allowing continuous reaction monitoring without substrate modification .

Experimental Setup:

  • Enzyme concentration: Low nanomolar to high picomolar range

  • Substrate concentration: 5-10× greater than KM (high micromolar if KM unknown)

  • Buffer conditions: Matched between enzyme and substrate through dialysis

  • Injection protocol: 2-4 minutes between injections with minimal substrate depletion (<5%)

Data Analysis for Michaelis-Menten Parameters:

  • First experiment: Determine differential power change (dQ/dt) proportional to substrate turnover

  • Second experiment: Determine reaction enthalpy by converting all substrate to product

  • Plot rate (d[P]/dt) vs. substrate concentration [S] to generate Michaelis-Menten curve

ParameterMeasurement ApproachTypical Range for mtnN
KM (μM)Michaelis-Menten or Lineweaver-Burk plot10-100 μM
kcat (s-1)d[P]/dt at saturating substrate1-50 s-1
kcat/KM (M-1s-1)Efficiency calculation105-107 M-1s-1
Ki (inhibitors)Progress curve analysisPicomolar-nanomolar

The ITC approach is particularly advantageous as it eliminates the need for artificial chromophores and provides continuous measurement without the need to quench the reaction at various timepoints .

How can site-directed mutagenesis be used to investigate catalytic mechanisms of Vibrio vulnificus mtnN?

Site-directed mutagenesis provides valuable insights into the catalytic mechanisms of V. vulnificus mtnN by enabling systematic modification of key residues. An effective approach includes:

Strategic Targets for Mutagenesis:

  • Catalytic Residues

    • Conserved aspartate residues involved in acid/base catalysis

    • Residues coordinating the nucleophilic water molecule

    • Amino acids stabilizing the transition state

  • Substrate Binding Pocket

    • Residues forming the hydrophobic pocket for adenine binding

    • Amino acids interacting with the 5'-substituent (methylthio/homocysteine)

    • Residues providing specificity for different substrates

Experimental Protocol:

  • Mutation Design:

    • Select residues based on sequence alignment with characterized MTANs

    • Design complementary primers containing desired mutations

    • Perform PCR-based mutagenesis

  • Functional Analysis:

    • Express and purify mutant proteins

    • Determine kinetic parameters using ITC or other methods

    • Compare catalytic efficiency (kcat/KM) between wild-type and mutants

Case Study: Transition State Analysis
Studying V. vulnificus mtnN can follow approaches similar to those used for V. cholerae MTAN, which revealed that:

  • The enzyme exhibits a late dissociative transition state

  • The ratio of dissociation constants for 5'-substituted ImmAs and DADMe-ImmAs (KImmA/KDADMe-ImmA) is approximately 137, indicating strong preference for transition state analogues resembling a late transition state

  • This preference is similar to E. coli and S. pneumoniae MTANs

This information guides the design of effective transition state analogue inhibitors with picomolar binding affinities.

How do transition state analogue inhibitors affect Vibrio vulnificus mtnN activity?

Transition state analogue inhibitors represent powerful tools for studying and potentially targeting V. vulnificus mtnN. Based on studies with related MTANs:

Mechanism of Inhibition:
Transition state analogues mimic the structure of the reaction's transition state, binding with significantly higher affinity than substrates. For V. cholerae MTAN, which shares structural similarities with V. vulnificus mtnN, several transition state analogues show exceptional potency:

  • 5'-methylthio-DADMe-ImmucillinA (MT-DADMe-ImmA): Dissociation constant of 73 pM

  • 5'-ethylthio-DADMe-ImmucillinA (EtT-DADMe-ImmA): Dissociation constant of 70 pM

  • 5'-butylthio-DADMe-ImmucillinA (BuT-DADMe-ImmA): Dissociation constant of 208 pM

These inhibitors demonstrate slow-onset, tight-binding characteristics with time-dependent inhibition patterns .

Structural Interactions:
Structural analysis of V. cholerae MTAN complexed with BuT-DADMe-ImmucillinA reveals specific interactions contributing to high-affinity binding . These likely include:

  • Hydrogen bonding networks with the base moiety

  • Hydrophobic interactions with the alkylthio substituent

  • Specific contacts stabilizing the transition state mimic

Application in Research:
Transition state analogues provide valuable tools for:

  • Probing the enzymatic mechanism of mtnN

  • Investigating the role of mtnN in quorum sensing pathways

  • Potentially developing therapeutic approaches targeting V. vulnificus infections

How does inhibition of mtnN affect quorum sensing and virulence in Vibrio vulnificus?

Inhibition of mtnN has significant downstream effects on quorum sensing pathways and virulence expression in V. vulnificus:

Quorum Sensing Disruption Mechanisms:

  • Autoinducer-2 (AI-2) Pathway Disruption:

    • mtnN inhibition blocks the recycling of S-adenosylhomocysteine (SAH)

    • This disrupts the production of 4,5-dihydroxy-2,3-pentanedione (DPD), the AI-2 precursor

    • Results in impaired cell-to-cell communication

  • Impact on Virulence Factor Expression:

    • Reduced expression of MARTX toxins, which are important virulence factors in V. vulnificus

    • Decreased production of extracellular enzymes like proteases

    • Impaired biofilm formation capacity

The genetic variation observed in the rtxA1 gene encoding MARTX toxins in V. vulnificus represents an interesting parallel to consider. These toxins show different arrangements of effector domains across strains, with the clinical isolates surprisingly showing reduced toxin potency compared to environmental strains . This suggests complex regulatory patterns that may be influenced by quorum sensing pathways involving mtnN.

Potential Therapeutic Applications:
Targeting mtnN with specific inhibitors represents an anti-virulence strategy that could potentially reduce pathogenicity without imposing strong selective pressure for resistance development. This approach may be particularly valuable given the ongoing genetic rearrangement of virulence factors observed in V. vulnificus .

What structural features determine substrate specificity in Vibrio vulnificus mtnN?

The substrate specificity of V. vulnificus mtnN is determined by key structural features within its active site and binding pocket:

Key Structural Determinants:

  • Nucleoside Binding Pocket:

    • A hydrophobic pocket accommodates the adenine base

    • Specific hydrogen-bonding residues recognize adenine N1, N6, and N7

    • Conserved interactions with the ribose hydroxyl groups

  • 5'-Substituent Binding Region:

    • Flexible region that accommodates the methylthio group of MTA or the homocysteine moiety of SAH

    • Hydrophobic residues interact with the methylthio substituent

    • Extended binding capacity for the larger homocysteine group

  • Catalytic Architecture:

    • Conserved aspartate residue functioning as a catalytic acid/base

    • Precisely positioned water molecule for nucleophilic attack

    • Residues stabilizing the transition state

Transition State Characteristics:
Based on analysis of related MTANs, V. vulnificus mtnN likely exhibits a late dissociative transition state similar to that observed in V. cholerae and E. coli MTANs . This is evidenced by:

  • Strong preference for transition state analogues resembling late transition states

  • Higher affinity for DADMe-ImmA compounds compared to ImmA inhibitors

  • Distinctive binding interactions for 5'-substituted inhibitors

Understanding these structural determinants is crucial for rational inhibitor design and for engineering enzymes with modified substrate preferences.

How does the structure of Vibrio vulnificus mtnN compare to MTANs from other bacterial species?

The structure of V. vulnificus mtnN shares significant homology with MTAN enzymes from other bacterial species while possessing distinctive features:

Structural Similarities and Differences:

Inhibitor Binding Characteristics:
Analysis of transition state analogue binding provides insight into structural comparisons:

  • V. cholerae MTAN binds MT-DADMe-ImmA, EtT-DADMe-ImmA, and BuT-DADMe-ImmA with dissociation constants of 73, 70, and 208 pM, respectively

  • This binding affinity is intermediate between E. coli MTAN (low picomolar) and S. pneumoniae MTAN (nanomolar)

  • These differences reflect subtle structural variations in the binding pocket

Understanding these structural relationships aids in predicting V. vulnificus mtnN properties and guides approaches for specific inhibitor development.

How does genetic variation in mtnN affect enzyme kinetics and virulence potential?

Genetic variation in the mtnN gene can significantly impact enzyme kinetics and virulence potential in V. vulnificus:

Impact on Enzyme Kinetics:
Mutations in the mtnN gene can alter several kinetic parameters:

Parallels with rtxA1 Variation:
The observed genetic variation in mtnN is reminiscent of the well-documented variation in the rtxA1 gene encoding MARTX toxins in V. vulnificus. Studies have identified four distinct variants of rtxA1 that encode toxins with different arrangements of effector domains . This genetic rearrangement appears to have occurred through recombination either with rtxA genes carried on plasmids or with the rtxA gene of Vibrio anguillarum .

Virulence Implications:
Similar to how variation in rtxA1 affects toxin potency, with clinical isolates surprisingly showing reduced toxicity compared to environmental strains , variations in mtnN may:

  • Alter quorum sensing regulation efficiency

  • Modify virulence factor expression patterns

  • Affect bacterial adaptation to different environments (host vs. environmental)

  • Influence the emergence of strains with altered virulence potential

These findings suggest that key virulence factors in V. vulnificus are undergoing significant genetic rearrangement and may be subject to selection for reduced virulence in certain environments . This dynamic evolution could potentially lead to the emergence of novel strains with altered virulence characteristics in humans.

What role does mtnN play in the adaptation of Vibrio vulnificus to different environmental conditions?

The mtnN enzyme plays a crucial role in enabling V. vulnificus to adapt to diverse environmental conditions:

Environmental Adaptations Mediated by mtnN:

  • Nutrient-Limited Marine Environments:

    • Efficient recycling of methionine through the MTA cycle

    • Conservation of metabolic resources through nucleoside salvage pathways

    • Maintenance of essential cellular functions with minimal resource input

  • Host Infection Environment:

    • Coordination of virulence factor expression through quorum sensing regulation

    • Adaptation to host-imposed metabolic restrictions

    • Support of rapid growth required during infection progression

  • Temperature Fluctuations:

    • Maintenance of metabolic homeostasis across temperature ranges

    • Potential thermal regulation of quorum sensing pathways

    • Adaptation to transition between environmental and host temperatures

Metabolic Integration:
The mtnN enzyme functions within interconnected metabolic networks:

  • Methionine Cycle: Regeneration of this essential amino acid, particularly important under nutrient limitation.

  • S-Adenosylmethionine (SAM) Utilization: Support for methylation reactions and polyamine synthesis.

  • Quorum Sensing Regulation: Link between metabolic state and population density sensing.

The involvement of mtnN in these adaptive processes parallels observations regarding V. vulnificus virulence factors. The rtxA1 gene, for example, shows evidence of being "subject to selection for reduced virulence in the environment" , suggesting complex evolutionary pressures that may also affect mtnN function in different settings.

What are the most promising future research directions for Vibrio vulnificus mtnN studies?

Future research on V. vulnificus mtnN presents several promising directions that could advance understanding of bacterial metabolism, pathogenesis, and potential therapeutic interventions:

  • Structural Characterization:

    • High-resolution crystal structures of V. vulnificus mtnN with various substrates and inhibitors

    • Comparative analysis with MTAN structures from other pathogenic Vibrio species

    • Molecular dynamics simulations to understand conformational changes during catalysis

  • Genetic Variation Analysis:

    • Comprehensive survey of mtnN sequence variants across clinical and environmental V. vulnificus isolates

    • Correlation between mtnN variants and virulence potential

    • Investigation of selection pressures driving mtnN evolution in different environments

  • Metabolic Network Integration:

    • Systems biology approaches to understand mtnN's role in global metabolic networks

    • Metabolomic analysis of changes resulting from mtnN inhibition or deletion

    • Exploration of metabolic adaptations in different environmental conditions

  • Therapeutic Applications:

    • Development of highly specific mtnN inhibitors as potential anti-virulence agents

    • Investigation of combination approaches targeting multiple quorum sensing pathways

    • Evaluation of resistance development potential for anti-virulence strategies

  • Environmental Adaptation Mechanisms:

    • Investigation of mtnN regulation in response to environmental signals

    • Comparative analysis of mtnN function in pathogenic vs. non-pathogenic Vibrio species

    • Exploration of potential horizontal gene transfer and recombination events affecting mtnN

The ongoing genetic rearrangement of virulence factors in V. vulnificus, as demonstrated with the rtxA1 gene , suggests that similar dynamic evolution may be occurring with metabolic enzymes like mtnN. Future research should address how these changes might influence the emergence of novel V. vulnificus strains with altered virulence characteristics.

How might inhibition of mtnN be leveraged in potential therapeutic strategies?

Inhibition of mtnN presents a promising avenue for therapeutic intervention against V. vulnificus infections through several mechanisms:

Anti-Virulence Strategy:
Unlike conventional antibiotics that target bacterial viability, mtnN inhibitors could reduce pathogenicity without directly killing bacteria, potentially:

  • Disrupting quorum sensing-regulated virulence factor expression

  • Reducing the production of toxins, including the MARTX toxins critical for V. vulnificus pathogenicity

  • Impairing biofilm formation that contributes to antibiotic resistance

  • Limiting bacterial adaptation to the host environment

Therapeutic Advantages:
This approach offers several potential benefits:

  • Reduced Selection Pressure: Lower likelihood of resistance development compared to conventional antibiotics

  • Specificity: Targeting bacterial-specific metabolic pathways not present in humans

  • Combinatorial Potential: Synergistic effects when combined with conventional antibiotics

Implementation Approaches:
Developing effective mtnN-targeting therapeutics could involve:

  • Transition State Analogue Inhibitors: Building on the picomolar-affinity inhibitors demonstrated for V. cholerae MTAN

  • Structure-Based Drug Design: Utilizing structural insights to develop highly specific inhibitors

  • Prodrug Strategies: Creating compounds that are specifically activated in bacterial cells

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.